RE:RE:Being the first PDT treatment...Thank's lesflics... I should have been more specific in my title.
My title should have been,
TLT-Ruvidar is the first PDT treatment to treat cancer tumors in a FDA phase11 trial. All the approved treatments in your article are for stage0 cancer.
Stage 0 = Abnormal cells are present but have not spread to nearby tissue, also called
carcinoma in situs, or CIS, CIS is not cancer, but it could become a cancer tumor if left untreated.
In short...
TLT-Ruvidar treat real cancer tumors, not just CIS cells that precede cancer tumors
lesflics wrote: The FDA has approved photodynamic therapy to treat:
Photodynamic therapy is also used to relieve symptoms of some cancers, including:
- esophageal cancer when it blocks the throat
- non-small cell lung cancer when it blocks the airways
Photodynamic Therapy to Treat Cancer wildbird1 wrote: TLT-Ruvidar is the first PDT treatment to be in a FDA phase11 trial.
When TLT will negotiate a joint venture with a Big Pharma for the first FDA approved PDT treatment, the selling points for TLT-PDT will be many.
-TLT- PDT can cure patients that Valrubicin, Keytruda, Adstiladrin, CG- Oncology and N803+BCG couldn't cure(FDA approved treatments).
-TLT- PDT cancer treatment has a very high 450 days 37%TR(CR+PR).
-TLT- PDT cancer treatment has no side effects.
-TLT- PDT treatment can cure patients that surgery couldn't cure.
-TLT- PDT cancer treatment can cure patients that Chemotherapy & Radiotherapy couldn't cure.
-TLT- PDT cancer treatment can be adapted to treat many other cancer treatments.
-TLT- PDT treatment can cure patients after only one or two treatments.
- You can also add vaccines to the above.
Note:
Adstiladrin and N803+BCG did get the FDA-BTD approval with 450 days CR% numbers that are lower than TLT-Ruvidar.
For a Big Pharma being the first will implies to always be one step ahead of other future PDT treatments
All the above will add a huge $value to any Big Pharma deals.
I love my TLT shares.